Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis

• Published in: Haematologica (Roma) 2020-02, Vol.105 (2), p.375-386
• Main Authors: Caraffini, Veronica, Geiger, Olivia, Rosenberger, Angelika, Hatzl, Stefan, Perfler, Bianca, Berg, Johannes L, Lim, Clarice, Strobl, Herbert, Kashofer, Karl, Schauer, Silvia, Beham-Schmid, Christine, Hoefler, Gerald, Geissler, Klaus, Quehenberger, Franz, Kolch, Walter, Athineos, Dimitris, Blyth, Karen, Wölfler, Albert, Sill, Heinz, Zebisch, Armin
• Format: Article
• Language: English
• Subjects: Animals; Cell Differentiation; Leukemia, Myeloid, Acute - genetics; Mice; Monocytes - metabolism; Phosphatidylethanolamine Binding Protein - genetics; Phosphatidylethanolamine Binding Protein - metabolism; Signal Transduction
• ISSN: 0390-6078; 1592-8721
• DOI: 10.3324/haematol.2018.209650

-signaling mutations induce the myelomonocytic differentiation and proliferation of hematopoietic stem and progenitor cells. Moreover, they are important players in the development of myeloid neoplasias. RAF kinase inhibitor protein (RKIP) is a negative regulator of -signaling. As RKIP loss has recently been described in -mutated myelomonocytic acute myeloid leukemia, we now aimed to analyze its role in myelomonocytic differentiation and -driven leukemogenesis. Therefore, we initially analyzed RKIP expression during human and murine hematopoietic differentiation and observed that it is high in hematopoietic stem and progenitor cells and lymphoid cells but decreases in cells belonging to the myeloid lineage. By employing short hairpin RNA knockdown experiments in CD34 umbilical cord blood cells and the undifferentiated acute myeloid leukemia cell line HL-60, we show that RKIP loss is indeed functionally involved in myelomonocytic lineage commitment and drives the myelomonocytic differentiation of hematopoietic stem and progenitor cells. These results could be confirmed , where Rkip deletion induced a myelomonocytic differentiation bias in mice by amplifying the effects of granulocyte macrophage-colony-stimulating factor. We further show that RKIP is of relevance for -driven myelomonocytic leukemogenesis by demonstrating that deletion aggravates the development of a myeloproliferative disease in -mutated mice. Mechanistically, we demonstrate that RKIP loss increases the activity of the -MAPK/ERK signaling module. Finally, we prove the clinical relevance of these findings by showing that RKIP loss is a frequent event in chronic myelomonocytic leukemia, and that it co-occurs with -signaling mutations. Taken together, these data establish RKIP as novel player in -driven myeloid leukemogenesis.